Comparison of adjuvant FOLFOX4 chemotherapy and oral UFUR/LV following adjuvant FOLFOX4 chemotherapy in patients with stage III colon cancer subsequent to radical resection

The present study aimed to demonstrate the potential advantage of oral uracil-tegafur (UFUR)/leucovorin (LV) as the subsequent therapy in patients with stage III colon cancer following adjuvant LV, 5-fluorouracil and oxaliplatin (FOLFOX4) chemotherapy. Of a total 143 patients, 62 patients received o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Huang, Ming-Yii, Huang, Chun-Ming, Tsai, Hsiang-Lin, Huang, Ching-Wen, Hsieh, Hui-Min, Yeh, Yung-Sung, Wu, Jeng-Yih, Wang, Wen-Ming, Wang, Jaw-Yuan
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686528/
https://ncbi.nlm.nih.gov/pubmed/29163699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7073
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky